David Borkholder

Prof. David Borkholder

Rochester Institute of Technology

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2022 in Sensors
Verified
Journal Article
Open access
PDF file
KGKrittika Goyal
Krittika Goyal
David BorkholderDavid Borkholder
David Borkholder
SDSteven W Day
Steven W Day
Dry electrodes offer an accessible continuous acquisition of biopotential signals as part of current in-home monitoring systems but often face challenges of high-contact impedance that results in poor signal quality. The performance of dry electrodes could be affected by electrode material and skin hydration. Herein, we investigate these dependencies using a circuit skin-electrode interface model, varying material and hydration in controlled benchtop experiments on a biomimetic skin phantom simulating dry and hydrated skin. Results of the model demonstrate the contribution of the individual components in the circuit to total impedance and assist in understanding the role of electrode material in the mechanistic principle of dry electrodes. Validation was performed by conducting in vivo skin-electrode contact impedance measurements across ten normative human subjects. Further, the impact of the electrode on biopotential signal quality was evaluated by demonstrating an ability to capture clinically relevant electrocardiogram signals by using dry electrodes integrated into a toilet seat cardiovascular monitoring system. Titanium electrodes resulted in better signal quality than stainless steel electrodes. Results suggest that relative permittivity of native oxide of electrode material come into contact with the skin contributes to the interface impedance, and can lead to enhancement in the capacitive coupling of biopotential signals, especially in dry skin individuals.

18 January 2019 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
NCNicholas J Conn
Nicholas J Conn
KSKarl Q Schwarz
Karl Q Schwarz
David BorkholderDavid Borkholder
David Borkholder
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

1 March 2019 in Journal of Controlled Release
Verified
Journal Article
Closed access
FFFarzad Forouzandeh
Farzad Forouzandeh
XZXiaoxia Zhu
Xiaoxia Zhu
AAAHMED Alfadhel
AHMED Alfadhel
BDBo Ding
Bo Ding
JWJoseph P. Walton
Joseph P. Walton
David BorkholderDavid Borkholder
David Borkholder

1 October 2008 in Current Opinion in Otolaryngology & Head and Neck Surgery
Verified
Journal Article
Closed access
David BorkholderDavid Borkholder
David Borkholder
Purpose of review Treatment of auditory and vestibular dysfunction has become increasingly dependent on inner ear drug delivery. Recent advances in molecular therapy and nanotechnology have pushed development of alternate delivery methodologies involving both transtympanic and direct intracochlear infusions. This review examines recent developments in the field relevant to both clinical and animal research environments. Recent findings Transtympanic delivery of gentamicin and corticosteroids for the treatment of Meniere's disease and sudden sensorineural hearing loss continues to be clinically relevant, with understanding of pharmacokinetics becoming more closely studied. Stabilizing matrices placed on the round window membrane for sustained passive delivery of compounds offer more controlled dosing profiles than transtympanic injections. Nanoparticles are capable of traversing the round window membrane and cochlear membranous partitions, and may become useful gene delivery platforms. Cochlear and vestibular hair cell regeneration has been demonstrated by vector delivery to the inner ear, offering promise for future advanced therapies. Summary Optimal methods of inner ear drug delivery will depend on toxicity, therapeutic dose range, and characteristics of the agent to be delivered. Advanced therapy development will likely require direct intracochlear delivery with detailed understanding of associated pharmacokinetics.

1 January 2014 in Journal of Controlled Release
Verified
Journal Article
Closed access
David BorkholderDavid Borkholder
David Borkholder
XZXiaoxia Zhu
Xiaoxia Zhu
RFRobert Frisina
Robert Frisina

20 April 2016 in Journal of the American Ceramic Society
Verified
Journal Article
Closed access
PDF file
JOJing Ouyang
Jing Ouyang
DCDenis Cormier
Denis Cormier
SWScott A. Williams
Scott A. Williams
David BorkholderDavid Borkholder
David Borkholder